Volume 271, Number 44,
Issue of November 1, 1996
pp. 27201-27204
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Endothelial Cell Death Induced by Tumor Necrosis Factor-
Is
Inhibited by the Bcl-2 Family Member, A1
(Received for publication, July 24, 1996, and in revised form, September 3, 1996)
Aly
Karsan
,
Esther
Yee
and
John M.
Harlan
From the Division of Hematology, University of Washington, Seattle,
Washington 98195
Endothelial cells play a central role in the
inflammatory process. Tumor necrosis factor-
(TNF) is a
multifunctional cytokine which elicits many of the inflammatory
responses of endothelial cells. While TNF directly causes apoptosis of
tumor cells and virally infected cells, normal cells are generally
resistant. However, most resistant cells, including human endothelial
cells, can be rendered susceptible to TNF by inhibiting RNA or protein
synthesis. This finding suggests that TNF provides a cell survival
signal in addition to a death signal. We have previously cloned a human
Bcl-2 homologue, A1, and shown that it is specifically induced by
proinflammatory cytokines but not by endothelial growth factors. In
this study, we show that retroviral-mediated transfer of the A1
cDNA to a human microvascular endothelial cell line provides
protection against cell death initiated by TNF in the presence of
actinomycin D. The induction of A1 by TNF in this system is mediated
via a protein kinase C pathway. Since TNF signaling has also been shown
to proceed via ceramides, we tested whether exogenous ceramides could
induce A1. Our findings indicate that ceramides do not induce A1 but do
up-regulate c-jun and induce endothelial death.
Ceramide-activated endothelial death is also inhibited by A1,
suggesting that TNF may initiate divergent survival and death pathways
via separate lipid second messengers.